NPI: 1659576825 · KNOXVILLE, TN 37918 · Pediatric Nurse Practitioner · NPI assigned 06/18/2007
Authorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
| Authorized Official | ROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER) |
| Parent Organization | EAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER INC. |
| NPI Enumeration Date | 06/18/2007 |
Other providers sharing the same authorized official: ROSENDAHL, ANDREW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,197 | $193K |
| 2019 | 1,747 | $58K |
| 2020 | 2,497 | $74K |
| 2021 | 3,501 | $111K |
| 2022 | 3,036 | $110K |
| 2023 | 2,346 | $93K |
| 2024 | 401 | $16K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,229 | 3,674 | $268K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3,344 | 2,868 | $134K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 636 | 562 | $59K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 565 | 480 | $45K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 570 | 407 | $43K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 315 | 275 | $32K |
| 92551 | 1,547 | 1,286 | $17K | |
| 99177 | 3,081 | 2,629 | $16K | |
| 3008F | 2,661 | 2,297 | $7K | |
| 96161 | 518 | 424 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 734 | 613 | $6K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 312 | 286 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 32 | 30 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 101 | 89 | $3K |
| 90791 | Psychiatric diagnostic evaluation | 13 | 12 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 105 | 100 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 112 | 98 | $1K |
| 36416 | 606 | 507 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 22 | 20 | $1K |
| 83655 | 56 | 56 | $829.64 | |
| 99381 | 18 | 13 | $796.29 | |
| 96127 | 127 | 115 | $728.92 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12 | 12 | $615.72 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 32 | 31 | $550.70 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 46 | 44 | $506.44 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 25 | 15 | $279.94 |
| 82465 | 124 | 95 | $85.40 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 18 | 15 | $65.73 |
| 90686 | 683 | 609 | $24.15 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 25 | 15 | $0.66 |
| 90670 | 285 | 254 | $0.00 | |
| 90685 | 50 | 41 | $0.00 | |
| 90707 | 68 | 60 | $0.00 | |
| 90633 | 40 | 40 | $0.00 | |
| 90680 | 136 | 124 | $0.00 | |
| 90723 | 171 | 156 | $0.00 | |
| 90716 | 52 | 45 | $0.00 | |
| 90674 | 106 | 97 | $0.00 | |
| 90647 | 148 | 126 | $0.00 |